{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:23:28Z","timestamp":1760783008553},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,11,7]],"date-time":"2007-11-07T00:00:00Z","timestamp":1194393600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1245\/s10434-007-9670-7","type":"journal-article","created":{"date-parts":[[2007,11,6]],"date-time":"2007-11-06T16:12:14Z","timestamp":1194365534000},"page":"472-477","source":"Crossref","is-referenced-by-count":9,"title":["How Important is the Axillary Nodal Status for Adjuvant Treatment Decisions at a Breast Cancer Multidisciplinary Tumor Board? A Survival Analysis"],"prefix":"10.1245","volume":"15","author":[{"given":"Toralf","family":"Reimer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer","family":"Fietkau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Markmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angrit","family":"Stachs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,11,7]]},"reference":[{"key":"9670_CR1","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa020128","volume":"347","author":"B Fisher","year":"2002","unstructured":"Fisher B, Jeong JH, Anderson S, Bryant J, Fisher ER, Wolmark N. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 2002; 347:567\u201375","journal-title":"N Engl J Med"},{"key":"9670_CR2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00000658-199709000-00007","volume":"226","author":"EC Dees","year":"1997","unstructured":"Dees EC, Shulman LN, Souba WW, Smith BL. Does information from axillary dissection change treatment in clinically node-negative patients with breast cancer? Ann Surg 1997; 226:279\u201387","journal-title":"Ann Surg"},{"key":"9670_CR3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10434-999-0109-1","volume":"6","author":"RK Orr","year":"1999","unstructured":"Orr RK. The impact of prophylactic axillary node dissection on breast cancer survival\u2014a Bayesian meta-analysis. Ann Surg Oncol 1999; 6:109\u201316","journal-title":"Ann Surg Oncol"},{"key":"9670_CR4","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1200\/JCO.1999.17.5.1465","volume":"17","author":"G Parmigiani","year":"1999","unstructured":"Parmigiani G, Berry DA, Winer EP, Tebaldi C, Iglehart JD, Prosnitz LR. Is axillary lymph node dissection indicated for early-stage breast cancer? A decision analysis. J Clin Oncol 1999; 17:1465\u201373","journal-title":"J Clin Oncol"},{"key":"9670_CR5","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1093\/annonc\/mdl398","volume":"17","author":"A Goldhirsch","year":"2006","unstructured":"Goldhirsch A, Coates AS, Gelber RD, Glick JH, Th\u00fcrlimann B, Senn HJ. First\u2014select the target: better choice of adjuvant treatments for breast cancer patients. Ann Oncol 2006; 17:1772\u20136","journal-title":"Ann Oncol"},{"key":"9670_CR6","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.breast.2005.05.009","volume":"15","author":"J Engel","year":"2006","unstructured":"Engel J, Lebeau A, Sauer H, H\u00f6lzel D. Are we wasting our time with the sentinel technique? Fifteen reasons to stop axilla dissection. Breast 2006; 15:452\u20135","journal-title":"Breast"},{"key":"9670_CR7","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1200\/JCO.2005.03.6178","volume":"24","author":"IC Henderson","year":"2006","unstructured":"Henderson IC. Axillary surgery: clinical judgment required. J Clin Oncol 2006; 24:325\u20136","journal-title":"J Clin Oncol"},{"key":"9670_CR8","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/cncr.20786","volume":"103","author":"T Kuehn","year":"2005","unstructured":"Kuehn T, Bembenek A, Decker T, Munz DL, Sautter-Bihl ML, Untch M, Wallwiener D. A concept for the clinical implementation of sentinel lymph node biopsy in patients with breast carcinoma with special regard to quality assurance. Cancer 2005; 103:451\u201361","journal-title":"Cancer"},{"key":"9670_CR9","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/annonc\/mdi326","volume":"16","author":"A Goldhirsch","year":"2005","unstructured":"Goldhirsch A, Glick JH, Gelber RD, Coates AS, Th\u00fcrlimann B, Senn HJ. Meeting highlights: International expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol 2005; 16:1569\u201383","journal-title":"Ann Oncol"},{"key":"9670_CR10","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1200\/JCO.2001.19.4.980","volume":"19","author":"PM Ravdin","year":"2001","unstructured":"Ravdin PM, Siminoff LA, Davis GJ, Mercer MB, Hewlett J, Gerson N, Parker HL. Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. J Clin Oncol 2001; 19:980\u201391","journal-title":"J Clin Oncol"},{"key":"9670_CR11","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1046\/j.1524-4741.2003.09607.x","volume":"9","author":"B Chua","year":"2003","unstructured":"Chua B, Ung O, Taylor R, Boyages J. Is information from axillary dissection relevant to patients with clinically node-negative breast cancer? Breast J 2003; 9:478\u201384","journal-title":"Breast J"},{"key":"9670_CR12","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1023\/A:1008339331020","volume":"11","author":"M Greco","year":"2000","unstructured":"Greco M, Gennaro M, Valagussa P, et al. Impact of nodal status on indication for adjuvant treatment in clinically node negative breast cancer. Ann Oncol 2000; 11:1137\u201340","journal-title":"Ann Oncol"},{"key":"9670_CR13","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1002\/(SICI)1097-0142(20000415)88:8<1852::AID-CNCR14>3.0.CO;2-L","volume":"88","author":"JSH Jackson","year":"2000","unstructured":"Jackson JSH, Olivotto IA, Wai E, Grau C, Mates D, Ragaz J. A decision analysis of the effect of avoiding axillary lymph node dissection in low risk women with invasive breast carcinoma. Cancer 2000; 88:1852\u201362","journal-title":"Cancer"},{"key":"9670_CR14","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1200\/JCO.2005.06.178","volume":"23","author":"IA Olivotto","year":"2005","unstructured":"Olivotto IA, Bajdik CD, Ravdin PM, et al. Population-based validation of the prognostic model ADJUVANT! for early breast cancer. J Clin Oncol 2005; 23:2716\u201325","journal-title":"J Clin Oncol"},{"key":"9670_CR15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0360-3016(00)00605-2","volume":"48","author":"JS Wong","year":"2000","unstructured":"Wong JS, O\u2019Neill A, Recht A, Schnitt SJ, Connolly JL, Silver B, Harris JR. The relationship between lymphatic vessel invasion, tumor size, and pathological nodal status: can we predict who can avoid a third field in the absence of axillary dissection? Int J Radiat Oncol Biol Phys 2000; 48:133\u20137","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"9670_CR16","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/(SICI)1097-0142(19980901)83:5<948::AID-CNCR21>3.0.CO;2-U","volume":"83","author":"IA Olivotto","year":"1998","unstructured":"Olivotto IA, Jackson JSH, Mates D, Andersen S, Davidson W, Bryce CJ, Ragaz J. Prediction of axillary lymph node involvement of women with invasive breast carcinoma. Cancer 1998; 83:948\u201355","journal-title":"Cancer"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-007-9670-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-007-9670-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-007-9670-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T11:27:33Z","timestamp":1572953253000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-007-9670-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,7]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["9670"],"URL":"https:\/\/doi.org\/10.1245\/s10434-007-9670-7","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11,7]]}}}